Balchem Corporation (BCPC)

Market Cap	5.47B +14.2%
Revenue (ttm)	1.09B +10.1%
Net Income	164.41M +15.2%
EPS	5.08 +16.5%
Shares Out	31.88M
PE Ratio	33.79
Forward PE	28.55
Dividend	$0.96 (0.56%)
Ex-Dividend Date	Dec 31, 2026

Volume	21,582
Open	170.68
Previous Close	170.78
Day's Range	170.68 - 172.22
52-Week Range	146.21 - 183.90
Beta	0.85
Analysts	Buy
Price Target	209.25 (+21.9%)
Earnings Date	Oct 23, 2026

About BCPC

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended ...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 1967
• Employees: 1,352
• Stock Exchange: Nasdaq
• Ticker Symbol: BCPC
• Website: https://www.balchem.com

Financial Performance

In 2025, Balchem's revenue was $1.04 billion, an increase of 8.75% compared to the previous year's $953.68 million. Earnings were $154.85 million, an increase of 20.53%.

Analyst Summary

According to 3 analysts, the average rating for BCPC stock is "Buy." The 12-month stock price target is $209.25, which is an increase of 21.90% from the latest price.

Price Target

$209.25

(21.90% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Oct 22, 2026

Data Sources Report a data error